Rayon Genomics (688217.SH): 2023 net profit fell 79.93% year on year

Gelonghui Finance · Feb 23 03:44

Gelonghui, Feb. 23 | Ruiang Gene (688217.SH) announced its 2023 annual performance report. During the reporting period, the company achieved total revenue of 256.5730 million yuan, a decrease of 39.53% compared with the same period last year; realized operating profit - 7.244,400 yuan, down 110.10% from the same period last year; realized total profit - 9.9852 million yuan, down 113.84% from the same period last year; realized net profit attributable to the owner of the parent company, a decrease of 79.93% compared with the same period last year; realized ownership to the parent company The company owner's net profit after deducting non-recurring profit and loss was 4.192,400 yuan, a decrease of 87.52% compared with the same period last year; achieved basic earnings of 0.15 yuan per share, a decrease of 79.45% compared with the same period last year. As of the end of the reporting period, the company's total assets were RMB 104,39612 million, down 3.60% from the beginning of the reporting period; owners' equity attributable to the parent company was RMB 94.59819 million, an increase of 0.97% compared with the beginning of the reporting period.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more

睿昂基因(688217.SH)：2023年净利润同比下降79.93%

Rayon Genomics (688217.SH): 2023 net profit fell 79.93% year on year

Risk Disclaimer

Statement